Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07856693Not ApplicableNot Yet Recruiting

Bone and Soft Tissue Healing After Socket Preservation With NOVAMag or Permamem Membranes

Role: collaborator

NCT06059898Not ApplicableCompleted

Magnesium NOVAMag® Membrane vs. Collagen Jason® Membrane in Patients Requiring Guided Bone Regeneration

Role: collaborator

NCT07533110Phase 4Recruiting

Evaluation Of The Success Rate of NOVAMag® SHIELD

Role: collaborator

NCT06915675Not ApplicableActive Not Recruiting

Human Placenta Extract Use in Socket Preservation

Role: collaborator

All 4 trials loaded